JPRN-UMIN000001634Completed未知
Antiproteinuric effect of recombinant human erythropoietin (rHuEPO) in predialysis chronic kidney disease (CKD) patients: multicenter observational study - Antiproteinuric effect of rHuEPO in predialysis CKD patients
Osaka General Medical Center Department of Kidney Disease and Hypertension0 sites50 target enrollmentStarted: January 14, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with cancer, liver cirrhosis, maintenance dialysis and pregnancy were excluded. Patients who were started or changed with antihypertensives or diuretics or who required admission within 6 months before- and after- rHuEPO initiation.
Investigators
Similar Trials
Completed
Phase 2
The Effect of Erythropoeitin on Anemia of PrematurityAnemia of Prematurity.Anaemia of prematurityIRCT201112265110N2Vice Chancellor for Research and Tchnology, Hamadan University of Medical Sciences30
Completed
Not Applicable
comparison of two drugs which lowers proteinuria in diabetic kidney diseaseCTRI/2012/04/002550Sowmya Bondalapati100
Not yet recruiting
Not Applicable
Effect of recombinant human erythropoietin administration before cardiopulmonary bypass on the development of postoperative acute kidney injury in patients undergoing valvular heart surgeryDiseases of the circulatory systemKCT0000696Asan Medical Center228
Completed
Phase 1
The benefits of Erythropoietin in reducing the need for blood transfusions in patients receiving chemotherapysolid insitu tumor of the body.In situ neoplasmsD00-D09IRCT2015061822805N1Vice Chancellor for research of Tabriz University of Medical Sciences60
Active, not recruiting
Phase 1
Effects of recombinant human Erythropoietin on circulating and intramuscular endothelial progenitor cells, neovascularisation and oxidative metabolism of skeletal muscle in Friedreich’s AtaxiaEUCTR2008-000040-13-ATMedizinische Universität Innsbruck, Univ.-Klinik für Neurologie7